CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.120
-0.170 (-3.96%)
At close: Apr 28, 2026, 4:00 PM EDT
4.180
+0.060 (1.46%)
After-hours: Apr 28, 2026, 7:24 PM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $896.90 million as of April 28, 2026. Its market cap has increased by 2,164.90% in one year.
Market Cap
896.90M
Enterprise Value
764.09M
1-Year Change
2,164.90%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $896.90M, an increase of 12,020.25%. That is a compound annual growth rate of 57.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 730.10M | 1.15% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 1.01B |
| Omeros | 974.11M |
| Geron | 961.35M |
| Annexon | 955.54M |
| Xencor | 951.94M |
| Phathom Pharmaceuticals | 929.33M |
| Fortrea Holdings | 916.30M |
| Evommune | 914.15M |